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edin may be specific genetic traits of European
CA-MRSA.
In conclusion, etd was not associated currently
with bullous impetigo or generalised SSSS, both
of which are caused by ETs. However, etd was
associated with edin and lukS-PV–lukF-PV in CA-
MRSA strains spreading throughout Europe [15],
and this combination may contribute to epide-
micity and virulence.
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ABSTRACT
This study compared the in-vitro ability of
Enterococcus faecium isolates of different origin
to acquire vanA by conjugation in relation to the
occurrence of the esp gene. In total, 29 clinical
isolates (15 ⁄ 29 esp+), 30 normal intestinal micro-
flora isolates (2 ⁄ 30 esp+) and one probiotic strain
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(esp-) were studied with a filter-mating assay.
Conjugation events were confirmed by PCR
and pulsed-field gel electrophoresis. Among the
infection-derived isolates, the esp+ isolates had
higher conjugation frequencies compared with
esp- isolates (p < 0.001), with a median value of
6.4 · 10)6 transconjugants ⁄donor. The probiotic
strain was shown to acquire vanA vancomycin
resistance in in-vitro filter mating experiments.
Keywords Conjugation, enterococcal surface protein,
Enterococcus faecium, esp, vanA, vancomycin-resistance
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Enterococci with acquired resistances can serve as
a reservoir of resistance genes that may be
transferred to susceptible bacteria. Among En-
terococcus spp., conjugation is believed to be the
major mechanism of genetic exchange. Enterococ-
cal surface protein (Esp), encoded by the esp gene,
has been found to be enriched in Enterococcus
faecalis and Enterococcus faecium isolates of infec-
tious origin [1–5]. Esp is believed to have a role in
immune evasion [1], biofilm formation [6] and
adhesion [7,8]. It has been hypothesised, based on
DNA sequence analysis, that the esp gene was
acquired by enterococci before vancomycin-resist-
ance [2], which is supported by the fact that esp is
transferable [9]. It is important to learn about the
mechanisms by which enterococci gain resistance,
since acquisition of antibiotic resistance could be
regarded as an indirect virulence trait. The aim of
the present study was to determine the in-vitro
pheromone-independent conjugation frequencies
of E. faecium isolates of different origin, and the
relationship between conjugal ability and the
presence of the esp gene.
The study investigated the recipient ability of
60 E. faecium isolates, 30 from normal human
intestinal microflora, collected before drug
administration from the faeces of 30 healthy
volunteers [10,11], 29 from patients during 2000–
2002 with bacteraemia (duplicate isolates with an
identical pulsed-field gel electrophoresis (PFGE)
banding pattern were excluded), and one probi-
otic strain. All isolates were screened for the
presence of esp [1]. The esp gene was present in
15 ⁄ 29 blood culture isolates and in 2 ⁄ 30 normal
microflora isolates, but not in the probiotic strain.
Rifampicin resistance (rifr) was selected in all
recipient isolates. An E. faecium strain, CCUG
36804 (Culture Collection, University of Gothen-
burg, Sweden), harbouring the vanA gene cluster,
was used as the donor strain, and the conjugation
assay was performed as described previously
[12]. The conjugation frequency for each isolate
was calculated as the number of CFU transconju-
gants per CFU donor. All recipients and their
corresponding transconjugants were tested for the
presence of the vanA gene with PCR [13]. The
strain identities of the donors, recipients and
transconjugants were confirmed by PFGE [14,15].
All transconjugant colonies from one experiment
were pooled for the PFGE analysis in order to
exclude the possibility of spontaneous rifr
mutants of the donor strain. In the statistical
analysis, the strains were first grouped according
to origin, followed by subgrouping according to
the presence of esp. Differences in conjugation
frequencies between the groups and between
subgroups were calculated with the Mann–Whit-
ney U-test for unpaired observations. Differences
in the number of non-conjugants between the
total number of esp-positive and esp-negative
strains were analysed with the chi-square test.
p values £ 0.05 were considered significant.
Table 1 summarises the data from the conjuga-
tion assays. Isolates from blood and the normal
microflora that failed to yield detectable trans-
conjugants after filter mating (n = 22), i.e., with a
conjugation frequency below the detection limit
(< 10)7), were denoted as non-conjugants. All but
one of the infection-derived non-conjugants
Table 1. Summary of data from in-vitro conjugation
assays showing the total number of isolates and non-
conjugants in each group, and the corresponding range,
median and p values for conjugation frequencies per
donor
Groups
No. of
isolates
No. of
non-conjugants
Conjugation frequency,
transconjugants ⁄donor
Range Median value p valuea
B total 29 10 < 10)7-3.7 · 10)5 8.0 · 10)7 NS
N total 30 12 < 10)7-3.9 · 10)5 2.5 · 10)7
B esp+ 15 1 < 10)7-3.7 · 10)5 6.4 · 10)6 < 0.001
B esp- 14 9 < 10)7-1.2 · 10)5 < 10)7
esp+ total 17 3 < 10)7-3.7 · 10)5 5.6 · 10)6 < 0.05
esp- total 42 19 < 10)7-3.9 · 10)5 1.5 · 10)7
B esp- 14 9 < 10)7-1.2 · 10)5 < 10)7 NS
N esp- 28 10 < 10)7-3.9 · 10)5 7.0 · 10)7
B, blood-isolates; N, normal intestinal microflora isolates; NS, not significant.
ap calculated according to Mann–Whitney U-test for unpaired observations.
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lacked esp. The esp+ isolates had a significantly
higher conjugation frequency than esp– isolates,
but there was a tendency to higher conjugation
frequencies in the esp– isolates from normal
microflora in comparison with the esp– blood
isolates. There was a significant rate of conjuga-
tion for the probiotic strain (1.5 · 10)6). The vanA
PCR product was present in the donor strain and
all transconjugants, but was absent in the original
recipient isolates. All colonies regarded as poten-
tial transconjugants, i.e., those that grew on agar
plates supplemented with vancomycin and rif-
ampicin, were included in the PFGE analyses. The
banding pattern of each recipient showed pair-
wise identical patterns compared with the corres-
ponding transconjugants (Fig. 1).
The exact role of Esp in the infectious process
has not been clarified. Data obtained to date
suggest that it contributes to virulence by mul-
tiple mechanisms. The present investigation high-
lights the correlation between esp and conjugation
ability. The clinical esp+ isolates had a median
conjugation frequency that exceeded that of the
esp– isolates by a factor of 30. This connection may
be direct or indirect, reflecting the fact that Esp is
a known marker for strains with an increased
ability to cause infections, and that these strains
seem to have a parallel amplified potential for
dynamic changes of the genome. It can be specu-
lated that a strengthened ability to acquire new
genetic elements is advantageous in the infectious
situation. The fact that esp is believed to be an
acquired trait [2,9], and is found to be enriched in
infectious isolates [1–5], supports the hypothesis
that esp+ bacteria have an increased ability to
conjugate. If esp is a marker for increased viru-
lence, the results of the current study may
indicate that strains with an elevated capacity to
cause infection are also more likely to acquire
vancomycin resistance by conjugation.
There was no significant difference between
blood isolates and normal microflora isolates with
respect to conjugation frequencies, possibly be-
cause half of the blood isolates were esp– and this
group had a very low conjugation rate (Table 1).
It can be speculated that the gastrointestinal
tract offers favourable conditions for conjugation,
thereby explaining the tendency towards higher
conjugation frequencies among the esp– normal
microflora isolates in relation to the esp– blood
isolates.
In-vivo transfer of the VanA type of resistance
between E. faecium strains has been demonstrated
in the intestinal tract of germ-free mice [16]. The
results of the present study showed that the
probiotic strain could acquire the vanA gene
cluster under in-vitro conditions, which implies
that in-vivo conjugation events cannot be exclu-
ded and should be considered in risk assessments
of products containing probiotic strains.
In conclusion, E. faecium blood culture-derived
isolates harbouring esp had a significantly higher
ability to acquire the vanA gene cluster in vitro
when compared with esp– isolates, indicating that
a good ability to conjugate is a selective advantage
in the infectious situation.
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ABSTRACT
The Vitek 2 system was compared with conven-
tional assimilation, fermentation and morpholo-
gical methods for its ability to identify yeast
isolates from among 151 clinical specimens and 16
known type culture or quality control strains. An
unequivocal identification was obtained for 155
(92.8%) isolates, with low discrimination for nine
(5.4%) and false identification for three (1.8%)
isolates. All isolates of Candida albicans, Candida
glabrata and Candida krusei were identified cor-
rectly. It was concluded that the Vitek 2 system
offers an excellent alternative for the identification
of yeasts in a clinical laboratory.
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yeast
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Yeasts have gained increasing importance in
recent decades as aetiological agents of invasive
infections in immunocompromised and other
critically-ill patients [1–3]. Simultaneously, the
proportion of Candida spp. other than Candida
albicans has increased, including the fluconazole-
resistant species Candida glabrata and Candida
krusei [2,4–6]. Therefore, identification of yeasts
to the species level has become important in
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